-
Zydus and Lupin Partner to Co-Market Semaglutide Injection in India for Diabetes and Weight Management
March 17, 2026In a significant move for India’s healthcare and pharmaceutical sector, Zydus Lifesciences Ltd. and Lupin Limited...
-
Zydus to Launch Game-Changing Semaglutide in India — And It Could Transform Diabetes Care
February 26, 2026Ahmedabad-based Zydus Lifesciences Limited has announced plans to launch its innovative Semaglutide Injection in India immediately...
-
Zydus Hospitals Expands Vadodara Presence With VINS Hospital Acquisition
January 30, 2026Zydus Hospitals has strengthened its footprint in Gujarat by acquiring the Vadodara Institute of Neurological Sciences...
-
Triple-Targeted Drug Combination Shows Promise Against Pancreatic Cancer
January 30, 2026Pancreatic cancer is one of the most aggressive and lethal malignancies, with survival rates that have...
-
CORONA Remedies Limited Secures EAEU–GMP Certification, Strengthening Global Presence
January 22, 2026Ahmedabad-based CORONA Remedies Limited has achieved a major milestone in its international growth journey with the...
-
Zydus Receives USFDA Orphan Drug Designation for Desidustat in Beta-Thalassemia Treatment
November 6, 2025In a significant step toward advancing treatments for rare blood disorders, Zydus Lifesciences Limited has announced...
-
Russian mRNA Cancer Vaccine Enteromix Sparks Hope — But Experts Urge Caution
September 9, 2025Enteromix represents hope tempered with caution. The vaccine is a reminder that while science continues to...
